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Abstract 
Multiparous Holstein cows (n = 122) were used in a randomized block design to determine the effect of 
short-term and long-term postpartum administration of Scutellaria baicalensis extract (SBE) on 305-day 
milk yield, 120-day milk component yield, and early lactation milk markers of inflammation and metabolic 
function. Treatments were (1) control, (2) short-term (5-day) administration of the SBE (SBE5), and (3) 
longterm (60-day) administration of the SBE (SBE60). Treatments were included in a treatment pellet that 
was identical to the control pellet in ingredient source and composition except for the extract, and both 
pellets were provided via an automated milking system. Milk samples were collected on day 1, 3, and 
once during days 5–12 of lactation, followed by weekly sampling for the remainder of the 120 days 
collection period. Milk samples collected in the first 2 weeks were used for biomarker analysis 
(haptoglobin and β-hyroxybutyrate [BHBA]), and all samples were used for composition analysis. Cows 
were scored for body condition every 2 weeks prepartum and postpartum. Milk production, programmed 
pellet allocation, and actual provision of both pelleted feeds were recorded daily. There was no difference 
in daily treatment pellet feeding between SBE5 and SBE60 for the first 5 days of lactation. Total pellet 
intake was greater for SBE60 than SBE5 and control cows during the treatment period (weeks 1–9), but 
not during the carryover period (weeks 10–36). No treatment effects were observed for body condition, 
milk haptoglobin, or milk BHBA. Whole-lactation milk yield was increased for SBE60 compared to control, 
but SBE5 did not differ from control. Milk lactose and fat yields were significantly greater and milk protein 
yield tended to be greater for SBE60 than control. Treatment SBE60 decreased somatic cell count (SCC) 
compared to control during weeks 3–5 and 8, whereas SBE5 did not affect SCC. Mastitis incidence was 
lesser for both SBE5 and SBE60 compared to control. Time to pregnancy did not differ, but retention in the 
herd tended to be greater for SBE60 than control. In conclusion, despite no detected treatment effects on 
BCS or milk biomarkers of inflammation and metabolic status, supplementation of postpartum dairy 
cows with Scutellaria baicalensis extract for 60 days was effective at decreasing mastitis incidence and 
increasing milk yield. 
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Summary
Multiparous Holstein cows (n = 122) were used in a randomized block design to deter-
mine the effect of short-term and long-term postpartum administration of Scutellaria 
baicalensis extract (SBE) on 305-day milk yield, 120-day milk component yield, and 
early lactation milk markers of inflammation and metabolic function. Treatments were 
(1) control, (2) short-term (5-day) administration of the SBE (SBE5), and (3) long-
term (60-day) administration of the SBE (SBE60). Treatments were included in a 
treatment pellet that was identical to the control pellet in ingredient source and compo-
sition except for the extract, and both pellets were provided via an automated milking 
system. Milk samples were collected on day 1, 3, and once during days 5–12 of lactation, 
followed by weekly sampling for the remainder of the 120 days collection period. Milk 
samples collected in the first 2 weeks were used for biomarker analysis (haptoglobin and 
β-hyroxybutyrate [BHBA]), and all samples were used for composition analysis. Cows 
were scored for body condition every 2 weeks prepartum and postpartum. Milk produc-
tion, programmed pellet allocation, and actual provision of both pelleted feeds were 
recorded daily. There was no difference in daily treatment pellet feeding between SBE5 
and SBE60 for the first 5 days of lactation. Total pellet intake was greater for SBE60 
than SBE5 and control cows during the treatment period (weeks 1–9), but not during 
the carryover period (weeks 10–36). No treatment effects were observed for body 
condition, milk haptoglobin, or milk BHBA. Whole-lactation milk yield was increased 
for SBE60 compared to control, but SBE5 did not differ from control. Milk lactose 
and fat yields were significantly greater and milk protein yield tended to be greater for 
SBE60 than control. Treatment SBE60 decreased somatic cell count (SCC) compared 
to control during weeks 3–5 and 8, whereas SBE5 did not affect SCC. Mastitis inci-
dence was lesser for both SBE5 and SBE60 compared to control. Time to pregnancy 
did not differ, but retention in the herd tended to be greater for SBE60 than control. In 
conclusion, despite no detected treatment effects on BCS or milk biomarkers of inflam-
mation and metabolic status, supplementation of postpartum dairy cows with Scutel-
laria baicalensis extract for 60 days was effective at decreasing mastitis incidence and 
increasing milk yield.
1 Groupe CCPA, Janzé, France. 




Inflammation during the transition period has been well established and is associated 
with reduced milk yield and reproductive performance. Previous research demonstrated 
that short-term postpartum administration (3 days) of the nonsteroidal anti-inflamma-
tory drugs (NSAID) sodium salicylate and meloxicam increases whole-lactation milk 
and protein yields. The fact that use of NSAIDs during early lactation is considered 
off-label drug use, has encouraged investigation of plant extracts as a natural alterna-
tive. Extracts from the Scutellaria baicalensis plant, containing several flavonoids, have 
shown anti-inflammatory and antioxidant properties in cell culture experiments. 
The objective of this study was to determine the effect of short-term (5-day) and 
long-term (60-day) administration of Scutellaria baicalensis extract (SBE) after calving 
on milk yield and milk markers of inflammation and metabolic function. Secondary 
outcomes examined were effects of SBE on milk components, somatic cell count, time 
to pregnancy, disease incidence, and retention in the herd.
Experimental Procedures
Multiparous Holstein cows (n = 122) on a commercial farm were used in a random-
ized block design to determine the effects of short-term (5-day) and long-term (60-day) 
postpartum administration of SBE on 305-day milk yield and early lactation milk 
markers of inflammation and metabolic function. Cows were blocked by parity (2 and 
3+), calving date, and risk factors (high risk block: calving difficulty score ≥ 3 or twins), 
then randomly assigned within block to one of three treatments. Upon calving, cows 
were moved into a fresh pen where they had free access to an automatic milking system 
(AMS; Austronaut A3, Lely Ltd., Maassluis, The Netherlands), but were encouraged 
through the AMS if their voluntary attendance was less than 3 visits that day. Cows 
were managed per site standard operating procedures. 
Cows were fed a partial mixed ration (PMR) twice daily and were provided with 
pelleted concentrate feed in the AMS. S. baicalensis extract (Groupe CCPA, Janze, 
France) was combined with the dairy’s standard robot feed formulation and pelleted. 
The control and treatment pelleted feeds were stored in two feed bins that indepen-
dently supplied the milking robots. Treatments were (1) control (n = 39), (2) short-
term (5-day) administration after calving of the SBE pellet (n = 42; SBE5), and (3) 
long-term (60-day) administration after calving of the SBE pellets (n = 40; SBE60). 
Treatments began within 24 hours after calving. All cows received the control pellet, 
with the amount based on stage of lactation and milk production. Treatment cows were 
allocated 1.8 kg of the treatment pellet (delivering 100 g test material/day) in place 
of an equal amount of control pellet across all milkings for either 5 or 60 days. Pellet 
allocation was based solely on days in milk (DIM) during the first 50 days of lactation, 
then from day 51 until 2 weeks prior to dry off, total pellet allocation was based on a 
feed table, which incorporated milk production. The feeding program distributed the 
target amount of treatment feed across the average number of daily milkings per cow. 
Due to the nature of AMS, voluntary deviations from a cow’s average number of milk-
ings resulted in slight excesses or shortfalls in actual provision of pellet compared to 
the targeted allocation, and instances when not all the feed allocated for that particular 
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milking was dispensed were recorded as rest feed. Reported pellet intake is the differ-
ence between total pellet allowance and rest feed. 
The PMR, control pellets, and treatment pellets were sampled every 2 weeks and 
composited by month for nutrient analysis by Dairy One Forage Laboratory (Ithaca, 
NY). Nutrient analyses are reported as averages across the study for the PMR in Table 1 
and the pelleted feeds in Table 2. 
Milk samples were collected on days 1, 3, and once during days 5–12 of lactation, 
followed by weekly sampling for the remainder of the 120-day collection period. Milk 
samples collected during the first 2 weeks of lactation were used for both biomarker 
analysis (haptoglobin and β-hydroxybutyrate [BHBA]) and component analysis; subse-
quent samples were used only for composition analysis. Milk composition was analyzed 
by MQT Lab Services (Kansas City, MO). 
Cows were scored every 2 weeks for body condition score (BCS) on a 5-point scale 
(1 = extremely thin to 5 = extremely obese) from week -3 to week 17 relative to calving. 
Daily milk production, DIM, number of milkings per day, programmed feed daily allo-
cated and feed provided for both pelleted feeds, and rumination data were recorded on 
an individual cow basis and collected using the management software, Time for Cows 
(T4C, Lely Ltd., Maassluis, The Netherlands). Culling data were reported in PC Dart 
by the farm staff.
Results and Discussion
Treatment Provision and Total Pellet Offered 
Test material delivered for the first 5 DIM was not different between SBE5 and SBE60 
(P = 0.41; 80.8 and 83.1 ± 0.34 g/day, respectively). Mean test material provision for 
SBE60 ranged between 92 and 98 g/d during weeks 1–9 of lactation. Pellet feeding 
records (T4C) confirmed that no treatment feed was allocated to control cows nor to 
SBE5 cows after day 5 of lactation. Total pellet offered over the first 63 DIM (Table 3) 
differed by treatment and week, and had a treatment × week interaction (all P < 0.001; 
Figure 1). Pellet offered was greater for SBE60 cows compared to control cows during 
week 1–9 (P < 0.001) and tended to be increased across week 1–36 (P < 0.10). Daily 
rumination time through 120 DIM was not different for control cows compared to 
either SBE5 or SBE60 over weeks 1–9 or 10–17 (all P > 0.55) and no treatment × week 
interaction was observed (P = 0.39; Table 3).
Milk Production and Composition 
Milk yield did not differ between SBE5 and control, during the treatment period 
(weeks 1–9; P = 0.35) or the carryover period (weeks 10–43; P = 0.73). Milk yield 
tended to increase for SBE60 compared to control during weeks 1–9 (P = 0.07) and 
was significantly increased during week 10–43 (P = 0.04; Figure 2). Whole-lacta-
tion milk yields (305-day) were 24,795, 25,596, and 27,924 ± 1,026 lb for control, 
SBE5, and SBE60; significant differences were detected between SBE60 and control 
(P = 0.03), but not between SBE5 and control (P = 0.60). Milking frequency was not 
affected by either SBE5 (P = 0.60) or SBE60 (P = 0.19) during the first 63 DIM, but 
milking frequency was increased for SBE60 during the carryover period compared 
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to control (P = 0.04) whereas no difference was detected between SBE5 and control 
(P = 0.48). As expected, milking frequency differed by week (P < 0.001), but no overall 
treatment × week interaction was observed (P = 0.11). Despite the difference in 
milking frequency, milk yield per milking did not differ by treatment during the treat-
ment or carryover periods (all P > 0.65). 
Milk composition data during the first 17 weeks of lactation are summarized in 
Table 4. There were no treatment effects on milk fat or protein concentration during 
the treatment or carryover periods (all P ≥ 0.15). Milk lactose concentration tended to 
be increased for SBE60 compared to control during the treatment period (P = 0.06), 
but not the carryover period (P = 0.25), and was not affected by SBE5. Milk fat yield 
was increased in SBE60 during both the treatment and carryover period compared to 
control (both P = 0.04), whereas SBE5 was not different from control in either period 
(both P ≥ 0.50). Milk protein yield tended to be increased for SBE60 compared to 
control in the treatment period (P = 0.09) and was statistically greater during the carry-
over period (P = 0.01), but again did not differ between SBE5 and control (P ≥ 0.13). 
Milk lactose yield was increased for SBE60 but not SBE5 compared to control during 
the treatment period (P = 0.03 and 0.26, respectively). During the carryover period, 
milk lactose yield continued to be greater for SBE60 compared to control (P = 0.02), 
and SBE5 tended to increase milk lactose yield compared to control (P = 0.07).
Somatic cell count was decreased by SBE60 compared to control during the treatment 
period (P = 0.02) with a tendency for a difference in week 3 and significant effects in 
weeks 4–6 and 8 (Figure 3). Treatment SBE5 did not affect SCC (P = 0.37) during 
weeks 1–9, and neither SBE5 or SBE60 affected SCC during the carryover period 
(P = 0.29 and 0.13, respectively).
Overall there was no treatment effect on BCS (P = 0.44) with means being 3.40, 3.30, 
and 3.31 ± 0.06 for control, SBE5, and SBE60. As anticipated, body condition score 
differed by week (P < 0.001), but there was no treatment effect on prepartum or post-
partum BCS (treatment × week: P = 0.57).
Milk Markers of Inflammation and Metabolism 
Neither milk haptoglobin nor milk BHBA showed significant treatment effects 
(P = 0.97 and 0.89, respectively; Table 5) or treatment × DIM effects (P = 0.45 and 
0.47). Milk haptoglobin concentrations were greatest the day after calving (when 
inflammation is greatest) and subsequently declined for day 3 and day 5–12 milk 
samples (P < 0.001). The BHBA concentration also had a DIM effect (P < 0.0001), 
increasing from day 1 to day 5–12 samples.
Time to Pregnancy, Disease Incidence, and Herd Retention 
Survival analyses through 305 DIM were completed for time to pregnancy and removal 
from the herd. There was no treatment effect on time to pregnancy (P = 0.34). At 365 
days after treatment initiation, 13 of 40 control, 15 of 44 SBE5, and 6 of 38 SBE60 
cows had left the herd, and after accounting for other risk factors, SBE60 tended to 
decrease the risk of removal from the herd by 64% compared to control (P = 0.07; risk 
ratio for removal: 0.41, 95% confidence interval: 0.11, 0.99). Treatment SBE5 did not 
affect retention in the herd. Incidence of several diseases are reported in Table 6. The 
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only disease incidence affected by treatment was mastitis, being lesser for both SBE5 
and SBE60 compared to control (P = 0.04 and 0.05, respectively). Treatment SBE60 
tended to decrease the hazard of leaving the herd compared to control and SBE5 
(P = 0.07).
Conclusions
Supplementation of dairy cows with Scutellaria baicalensis for 60 days increased whole-
lactation milk yield compared to control cows. Milk fat, protein, and lactose yields 
increased through 120 DIM and SCC was decreased during the treatment period for 
the 60-d treatment compared to control cows. Milk production parameters were not 
different for short-term administration (5-day) compared to control cows. Other than 
milk SCC and reduced incidence of mastitis, there were no suggestions of impacts on 
health outcomes. Time to pregnancy was unaffected, but retention in the herd was 
increased. Overall, long-term administration of S. baicalensis effectively increased milk 
production, although the mechanism by which this was achieved is unknown. 
Table 1. Nutritional composition of the partial mixed ration (PMR)
Nutrient % of dry matter (DM) Standard deviation
DM, % as-fed 57.06 0.27
Crude protein 18.71 0.37
Acid detergent fiber 20.89 1.54
Neutral detergent fiber 31.96 2.31
Net energy for lactation, Mcal/kg 1.65 0.04
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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Table 2. Ingredient and nutritional composition of the control and treatment pellet
Item Control pellet Treatment pellet Standard deviation
Ingredient, % of dry matter (DM) 
Ground corn 42.47 42.44
Wheat middlings 27.76 27.23
Wheat flour 15.16 10.10
Soybean meal (47.5%) 10.92 10.92
Molasses 3.16 3.16
Super bind1 0.53 0.53
Test feed premix2 --- 5.62
Nutrient, analyzed, % of DM (unless otherwise specified)
DM, % as-fed 87.60 87.44 0.81
Crude protein 17.33 17.30 0.38
Acid detergent fiber 6.77 5.30 0.70
Neutral detergent fiber 15.33 14.52 0.94
NEL,
3 Mcal/kg 1.94 1.94 0.02
1Modified lignin sulfonate pellet binder (Bonaventure Chemicals, Inc., Weston, FL).
2Test feed premix included wheat flour, calcium carbonate, natural flavoring and Scutellaria baicalensis extract.
3Net energy for lactation.
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Table 3. Treatment means for weekly total pellet offered, milk yield, and milking 
frequency for cows fed control or S. baicalensis extract for either 5 days (SBE5) or 60 
days (SBE60) following calving
P-values





Total pellet offered, lb/d
d 1-63 11.6 11.7 12.5 0.31 0.77 < 0.01
d 64–301 11.0 11.4 11.6 0.33 0.13 0.02
Milk yield, lb/d
d 1–63 93.6 99.1 104.1 4.4 0.35 0.07
d 64–301 78.0 79.9 88.2 4.2 0.73 0.04
Milking frequency, d-1
d 1–63 3.24 3.34 3.48 0.21 0.60 0.19
d 64–301 2.56 2.67 2.84 0.18 0.48 0.04
Milk per visit, lb
d 1–63 30.6 31.2 31.1 1.65 0.70 0.75
d 64–301 31.0 30.6 31.0 1.39 0.92 0.99
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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Table 4. Rumination time through 120 DIM and milk composition for the first 17 weeks 
of lactation of control cows and cows supplemented with S. baicalensis extract (SBE) for 
either 5 days (SBE5) or 60days (SBE60) following calving
P-values






d 1–63 429.9 427.3 429.0 8.20 0.76 0.92
d 64–120 410.3 405.8 409.9 7.30 0.58 0.95
Milk fat, %
d 1–63 3.84 3.84 3.84 0.17 0.95 0.99
d 64–120 3.24 3.08 3.29 0.18 0.28 0.77
Milk protein, %
d 1–63 3.16 3.10 3.12 0.06 0.40 0.54
d 64–120 2.97 2.89 2.97 0.05 0.15 0.99
Milk lactose, %
d 1–63 4.87 4.89 4.95 0.04 0.54 0.06
d 64–120 4.92 4.95 4.97 0.04 0.46 0.25
Milk fat, lb/d
d 1–63 3.55 3.68 3.90 0.18 0.50 0.04
d 64–120 2.98 3.04 3.33 0.18 0.73 0.04
Milk protein, lb/d
d 1–63 2.95 3.09 3.22 0.13 0.42 0.09
d 64–120 2.71 2.95 3.11 0.11 0.13 0.01
Milk lactose, lb/d
d 1–63 4.63 4.92 5.20 0.22 0.26 0.03
d 64–120 4.56 5.03 5.18 0.20 0.07 0.02
SCC, log10 cells/mL
d 1–63 2.19 2.07 1.86 0.13 0.37 0.02
d 64–120 2.13 1.98 1.91 0.14 0.29 0.13
SCC = somatic cell count.
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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Table 5. Milk haptoglobin and BHBA on days 1, 3, and 5–12 of lactation for control cows and cows 
receiving S. baicalensis extract (SBE) for either 5 days (SBE5) or 60 days (SBE60) after calving
P-values1
Control SBE5 SBE60 SEM Trt DIM
Trt × 
DIM
Haptoglobin, µg/mL 0.97 < 0.001 0.45
d 1 4.98 3.54 5.47 1.04
d 3 1.53 1.70 1.44 0.35
d 5–12 0.59 0.69 0.50 0.13
BHBA, µM 0.89 < 0.001 0.47
d 1 264.0 265.3 249.4 23.6
d 3 639.7 609.7 632.2 22.6
d 5–12 729.1 746.7 717.8 18.6
1Treatment: P-value for treatment effect; DIM: P-value for time (days in milk) effect.
Table 6. Disease incidence through 250 DIM for control cows and cows receiving S. 
baicalensis extract (SBE) for either 5 days (SBE5) or 60 days (SBE60) after calving
Control SBE5 SBE60
At-risk 39 43 40
Fever 3 1 1
Milk fever 1 2 2
Displaced abomasum 0 0 0
Retained placenta 2 5 4
Metritis 3 4 6
Lame 2 2 0
Off feed 3 2 1
Mastitis1 13 6* 6*
Other 0 1 2
1Mastitis incidence tended to differ by treatment (P = 0.06). 
*Control vs. SBE5: P = 0.04. 
*Control vs. SBE60: P = 0.05.
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Figure 1. Weekly total pellet offered (control + treatment) of control cows and cows 
supplemented with S. baicalensis during the first 5 day (SBE5) or 60 day (SBE60) of lacta-
tion. 
Data were analyzed by treatment period (weeks 1–9) and carryover period (weeks 10–36). 
Total pellet offered was increased for SBE60 compared to control during the weeks 1–9 
(P < 0.01) and from weeks 10–43 (P = 0.02). Total pellet offered was not different between 
SBE5 and control during either weeks 1–9 (P = 0.77) or weeks 10–43 (P = 0.13). A treatment 
× week interaction was detected (P < 0.001), and differences between SBE60 and control are 
indicated by * (P < 0.05) and † (P < 0.10).
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Figure 2. Milk yield of control cows and cows supplemented with S. baicalensis extract 
(SBE) during the first 5 days (SBE5) or 60 days (SBE60) of lactation. 
Data were analyzed by treatment period (weeks 1–9) and carryover period (weeks 10–43). Milk 
yield tended to be increased for SBE60 compared to control from weeks 1–9 (P = 0.07) and 
was significantly increased from weeks 10–43 (P = 0.04). Milk yield was not different between 
SBE5 and control during weeks 1–9 (P = 0.35) or weeks 10–43 (P = 0.73). A treatment × week 
interaction was detected (P < 0.03), and differences between SBE60 and control are indicated 
by * (P < 0.05) and † (P < 0.10). 
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Figure 3. Somatic cell count (SCC) of control cows and cows supplemented with S. 
baicalensis extract (SBE) during the first 5 days (SBE5) or 60 days (SBE60) of lactation. 
Data were analyzed for the treatment period (weeks 1–9) and carryover period (weeks 10–17). 
Somatic cell count was not different between SBE5 and control during weeks 1–9 (P = 0.37) 
or weeks 10–17 (P = 0.29). Somatic cell count was decreased for SBE60 compared to control 
during weeks 1–9 (P = 0.02), but not during weeks 10–17 (P = 0.13). No treatment × week 
interaction was detected (P = 0.16). Differences between SBE60 and control are indicated by * 
(P < 0.05) and † (P < 0.10). 
